Diabetes Mellitus, Type 2SPARCNCT02318108
Supporting Practices to Adopt Registry-Based Care
A study testing Mentored organizational change and Education only in people with Diabetes Mellitus, Type 2, run by Mathematica Policy Research, Inc..
Trial summary
The purpose of this study is to test the effectiveness and cost effectiveness of an assisted work process redesign intervention in achieving improved diabetes care in primary care practices. Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Diabetes Mellitus, Type 2
- What is being tested?
- Mentored organizational change and Education only
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- No sites listed yet
- Study dates
- Jul 2012to Aug 2018
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- Primary care practice organizations with electronic health records.
- Located in Virginia
Who cannot join
- Not a primary care practice.
- No electronic health record.
- Located outside of Virginia.
About this study
Official title: Redesigning Diabetes Work Processes for Population-Based Primary Care: Supporting Practices to Adopt Registry-Based Care
The purpose of this study is to test the effectiveness and cost effectiveness of an assisted work process redesign intervention in achieving improved diabetes care in primary care practices. The strategies that we will test represent a novel method for assisting practices in developing the skills to overcome "clinical inertia" and health care system barriers to improved diabetes care by helping them to implement and use a diabetes registry to identify needed clinical or preventive services an opportunities for treatment intensification where appropriate for their patients with diabetes. This is accomplished by helping practices develop methods for improving the efficiency and effectiveness of clinical care processes through integration of a diabetes registry into regular clinical practice. This integration is accomplished through changes in the work processes in the practice setting to ensure that population health tasks (such as outreach to patients who do not attend scheduled chronic care visits and systematic identification for follow up of patients who may not be taking prescribed medication therapies) become a part of the regular work of clinical support staff and other members of the primary care practice team.
Read the detailed description
This project is designed to test the effectiveness and cost-effectiveness of a multi-faceted and largely self-directed organizational change intervention for implementation and use of diabetes registry in primary care practice. Participating practices will use a diabetes care registry to target evidence-based processes of care with the goal of improving patient attainment of recommended outcomes of care targets for HbA1c, blood pressure control and lipid control. Following recruitment and randomization of 30 primary care practices into intervention and control arms, clinician champions will be identified by practice leaders and attend a series of three meetings over the course of the intervention. At these meetings, champions will receive brief instruction in population health concepts, effective team leadership, organizational self-assessment, work process redesign and use of a computerized registry system. In addition, champions will share successes and challenges faced in the implementation process to encourage sharing successful techniques. At each participating practice, the clinician champion will be responsible for the intervention and will lead a process of organizational self-assessment and work process redesign to support implementation and use of a diabetes care registry. During the eleven-month implementation and initial registry use period an outside Peer Mentor will make quarterly visits to each practice and schedule monthly phone consultations with local clinician champions. During their visits, the Peer Mentors will meet with practice champions and advise them on methods for overcoming implementation barriers related to work process redesign. Peer Mentors will consult with a work process redesign expert as needed. For technical or computer-based barriers the Peer Mentor will coordinate access to a technical support staff member of the project.
Practice champion meetings The intervention will begin with a half-day training meeting for representatives from each of the 15 intervention practices who will then serve as "champions" for the intervention in their organizations. Prior to this stage, practice champions will be selected by practice leaders from among the clinicians in their practice using the following criteria: the clinician 1) has their principal employment in the practice, 2) is authorized to lead a practice improvement process and 3) regularly provides care to patients with diabetes. Practices may send more than one practice member to the training session (for example, a member of the nursing or clinical support staff could also attend the meeting). However, one clinician champion will be identified for each practice to ensure the maintenance of the relatively low cost of the intervention. In addition, practice managers will be provided with a detailed description of the intervention so that they can assist the champion in managing needed work process changes. Our experience in the pilot study suggests that a half-day session delivered in the evening is acceptable to primary care clinicians and is sufficient for delivery of the proposed training content. This meeting will be used to introduce practice champions to 1) the objectives of the project (including the focus on using the registry to target evidence-based processes of care improvements59 and cost-effective preventive care60), 2) population health concepts and how these relate to diabetes care in primary care practices, 3) principles of effective team leadership, 4) principles of patient registry construction and use, 5) an introduction to a free stand-alone registry software solution, 6) an organizational self-assessment process that focuses on planning work process changes related to using a registry in their practice, and 7) instruction in the use of study materials to coordinate changes in practice work processes with practice managers. Follow up meetings will be held at three and six months after the initial meeting of practice champions to assess progress with registry implementation, reinforce the learning from the initial meeting, and to share successes and challenges faced in the implementation process. The goal is that champions foster cross-practice learning by sharing successful techniques with each other. Peer Mentors will also attend these meetings.
Practice self-assessment and work process redesign Following the initial meeting of practice champions, practices will initiate a process of organizational self-assessment and work process redesign to ensure effective implementation and use of a diabetes registry. Clinician champions will use a self-assessment checklist designed to ensure that as part of this process champions focus on learning 1) current practice systems and procedures relating to diabetes care and the management and control of diabetes, 2) how these systems and procedures may be affected by registry use, and 3) which work processes will need to be changed or adapted to accommodate new registry-related work (including data entry, patient follow up, and visit preparation). Champions will then use these tools to focus on redesigning work processes to support these new tasks. These changes will necessarily be specific to each participating practice and will be tailored to the skills of the available staff members.
Peer Mentor activities The Peer Mentors will focus on assisting practice champions with addressing implementation and use hurdles specific to their practice. This assistance will be limited to an advisory role and will focus on reinforcing the need for practice champions to anticipate and plan for work process changes, encourage the development and use of effective team leadership techniques, and assist with addressing technical issues with regard to installation and use of the registry program. Peer Mentors will visit participating practices on a quarterly basis and have monthly phone conferences with practice champions throughout the 12-month intervention period.
Delayed intervention Based on initial findings from the evaluation of the intervention as delivered at baseline, we will adjust the intervention to focus on those activities from the initial intervention found to be most helpful for successful implementation and use of a diabetes registry. This modified intervention will be delivered, using a crossover design, to the initial control practices. Since the project timeline will not allow for long-term follow up of these practices we will compare the effectiveness of the initial and delayed interventions by comparing effects on patient outcomes observed in the first post-intervention assessment of initial intervention practices to effects on patient outcomes collected in the final observation period in delayed intervention practices.
Medical record review To assess the effect of the intervention on the quality of diabetes care delivered in participating practices, we will audit the medical records of 100 randomly selected patients with diabetes in each practice. The quality of diabetes care will be assessed for 100 patients from each practice at baseline, in year 3 following the initial intervention and then again in year 5 following the delivery of the delayed intervention to control practices for a total of 3000 medical records at each assessment period.
- Conditions
- Diabetes Mellitus, Type 2
- Being tested
- Mentored organizational change, Education only
- Keywords
- Organizational Innovation, Primary Health Care
- Medical subject headings
- Diabetes Mellitus, Type 2
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Mentored organizational changeOther
Practices are given basic education related to population-based care and are supported by physician peer mentors and given feedback on performance.
Education onlyOther
Practices are given basic education related to population-based care and are given feedback on performance.
| Study group | Role | What they receive |
|---|---|---|
| Intervention | Experimental | Mentored organizational change and feedback. Receives: Other: Mentored organizational change |
| Education only | Other | Education and feedback. Receives: Other: Education only |
What is being measured
The primary outcome is the main question the study is designed to answer.
Hemoglobin A1c
Assessment of HbA1c at baseline and two follow up points. Retrospective documentation of most recent value within previous year.
Measured: Change in HbA1c from baseline to follow up (year 1 and year 2)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Dec 2014 (estimated)
- Study startJul 2012
- Primary completionAug 2018 (estimated)
- Study completionAug 2018 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for Diabetes Mellitus, Type 2Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Mathematica Policy Research, Inc.
- Sponsor type
- University, hospital or other
- Collaborators
- Virginia Commonwealth University
- Responsible party
- Principal investigator, Jay Crosson, Mathematica Policy Research, Inc.
- Investigators
- Jay Crosson, Ph.D., Principal investigator, Mathematica Policy Research
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02318108
- Sponsor's protocol ID
- 12-323: 1R-01A1
- Acronym
- SPARC
- Status last verified
- Oct 2017
- First submitted
- 10 Dec 2014
- Last updated
- 17 Oct 2017
- Results posted
- No
- Data monitoring committee
- Yes
Publications
Sabo RT, Etz RS, Gonzalez MM, Johnson NJ, O'Neal JP, Reves SR, Crosson JC. Low-Intensity Intervention Supports Diabetes Registry Implementation: A Cluster-Randomized Trial in the Ambulatory Care Outcomes Research Network (ACORN). J Am Board Fam Med. 2020 Sep-Oct;33(5):728-735. doi: 10.3122/jabfm.2020.05.190455.
PubMed 32989067Keith RE, Crosson JC, O'Malley AS, Cromp D, Taylor EF. Using the Consolidated Framework for Implementation Research (CFIR) to produce actionable findings: a rapid-cycle evaluation approach to improving implementation. Implement Sci. 2017 Feb 10;12(1):15. doi: 10.1186/s13012-017-0550-7.
PubMed 28187747Etz RS, Keith RE, Maternick AM, Stein KL, Sabo RT, Hayes MS, Sevak P, Holland J, Crosson JC. Supporting Practices to Adopt Registry-Based Care (SPARC): protocol for a randomized controlled trial. Implement Sci. 2015 Apr 9;10:46. doi: 10.1186/s13012-015-0232-2.
PubMed 25885661
Study at a glance
From the registry record, last updated by the sponsor on 17 Oct 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Redesigning Diabetes Work Processes for Population-Based Primary Care: Supporting Practices to Adopt Registry-Based Care
- ClinicalTrials.gov ID
- NCT02318108
- Acronym / sponsor ID
- SPARC / 12-323: 1R-01A1
- Conditions
- Diabetes Mellitus, Type 2
- Keywords
- Organizational Innovation, Primary Health Care
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- Mathematica Policy Research, Inc.University, hospital or other
- Collaborators
- Virginia Commonwealth University
- Study start
- Jul 2012 (actual)
- Primary completion
- Aug 2018 (estimated)
- Study completion
- Aug 2018 (estimated)
- First posted
- 17 Dec 2014 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to test the effectiveness and cost effectiveness of an assisted work process redesign intervention in achieving improved diabetes care in primary care practices. The strategies that we will test represent a novel method for assisting practices in developing the skills to overcome "clinical inertia" and health care system barriers to improved diabetes care by helping them to implement and use a diabetes registry to identify needed clinical or preventive services an opportunities for treatment intensification where appropriate for their patients with diabetes. This is accomplished by helping practices develop methods for improving the efficiency and effectiveness of clinical care processes through integration of a diabetes registry into regular clinical practice. This integration is accomplished through changes in the work processes in the practice setting to ensure that population health tasks (such as outreach to patients who do not attend scheduled chronic care visits and systematic identification for follow up of patients who may not be taking prescribed medication therapies) become a part of the regular work of clinical support staff and other members of the primary care practice team.
Detailed description
This project is designed to test the effectiveness and cost-effectiveness of a multi-faceted and largely self-directed organizational change intervention for implementation and use of diabetes registry in primary care practice. Participating practices will use a diabetes care registry to target evidence-based processes of care with the goal of improving patient attainment of recommended outcomes of care targets for HbA1c, blood pressure control and lipid control. Following recruitment and randomization of 30 primary care practices into intervention and control arms, clinician champions will be identified by practice leaders and attend a series of three meetings over the course of the intervention. At these meetings, champions will receive brief instruction in population health concepts, effective team leadership, organizational self-assessment, work process redesign and use of a computerized registry system. In addition, champions will share successes and challenges faced in the implementation process to encourage sharing successful techniques. At each participating practice, the clinician champion will be responsible for the intervention and will lead a process of organizational self-assessment and work process redesign to support implementation and use of a diabetes care registry. During the eleven-month implementation and initial registry use period an outside Peer Mentor will make quarterly visits to each practice and schedule monthly phone consultations with local clinician champions. During their visits, the Peer Mentors will meet with practice champions and advise them on methods for overcoming implementation barriers related to work process redesign. Peer Mentors will consult with a work process redesign expert as needed. For technical or computer-based barriers the Peer Mentor will coordinate access to a technical support staff member of the project.
Practice champion meetings The intervention will begin with a half-day training meeting for representatives from each of the 15 intervention practices who will then serve as "champions" for the intervention in their organizations. Prior to this stage, practice champions will be selected by practice leaders from among the clinicians in their practice using the following criteria: the clinician 1) has their principal employment in the practice, 2) is authorized to lead a practice improvement process and 3) regularly provides care to patients with diabetes. Practices may send more than one practice member to the training session (for example, a member of the nursing or clinical support staff could also attend the meeting). However, one clinician champion will be identified for each practice to ensure the maintenance of the relatively low cost of the intervention. In addition, practice managers will be provided with a detailed description of the intervention so that they can assist the champion in managing needed work process changes. Our experience in the pilot study suggests that a half-day session delivered in the evening is acceptable to primary care clinicians and is sufficient for delivery of the proposed training content. This meeting will be used to introduce practice champions to 1) the objectives of the project (including the focus on using the registry to target evidence-based processes of care improvements59 and cost-effective preventive care60), 2) population health concepts and how these relate to diabetes care in primary care practices, 3) principles of effective team leadership, 4) principles of patient registry construction and use, 5) an introduction to a free stand-alone registry software solution, 6) an organizational self-assessment process that focuses on planning work process changes related to using a registry in their practice, and 7) instruction in the use of study materials to coordinate changes in practice work processes with practice managers. Follow up meetings will be held at three and six months after the initial meeting of practice champions to assess progress with registry implementation, reinforce the learning from the initial meeting, and to share successes and challenges faced in the implementation process. The goal is that champions foster cross-practice learning by sharing successful techniques with each other. Peer Mentors will also attend these meetings.
Practice self-assessment and work process redesign Following the initial meeting of practice champions, practices will initiate a process of organizational self-assessment and work process redesign to ensure effective implementation and use of a diabetes registry. Clinician champions will use a self-assessment checklist designed to ensure that as part of this process champions focus on learning 1) current practice systems and procedures relating to diabetes care and the management and control of diabetes, 2) how these systems and procedures may be affected by registry use, and 3) which work processes will need to be changed or adapted to accommodate new registry-related work (including data entry, patient follow up, and visit preparation). Champions will then use these tools to focus on redesigning work processes to support these new tasks. These changes will necessarily be specific to each participating practice and will be tailored to the skills of the available staff members.
Peer Mentor activities The Peer Mentors will focus on assisting practice champions with addressing implementation and use hurdles specific to their practice. This assistance will be limited to an advisory role and will focus on reinforcing the need for practice champions to anticipate and plan for work process changes, encourage the development and use of effective team leadership techniques, and assist with addressing technical issues with regard to installation and use of the registry program. Peer Mentors will visit participating practices on a quarterly basis and have monthly phone conferences with practice champions throughout the 12-month intervention period.
Delayed intervention Based on initial findings from the evaluation of the intervention as delivered at baseline, we will adjust the intervention to focus on those activities from the initial intervention found to be most helpful for successful implementation and use of a diabetes registry. This modified intervention will be delivered, using a crossover design, to the initial control practices. Since the project timeline will not allow for long-term follow up of these practices we will compare the effectiveness of the initial and delayed interventions by comparing effects on patient outcomes observed in the first post-intervention assessment of initial intervention practices to effects on patient outcomes collected in the final observation period in delayed intervention practices.
Medical record review To assess the effect of the intervention on the quality of diabetes care delivered in participating practices, we will audit the medical records of 100 randomly selected patients with diabetes in each practice. The quality of diabetes care will be assessed for 100 patients from each practice at baseline, in year 3 following the initial intervention and then again in year 5 following the delivery of the delayed intervention to control practices for a total of 3000 medical records at each assessment period.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Intervention | Experimental | Other: Mentored organizational changeMentored organizational change and feedback. |
| Education only | Other | Other: Education onlyEducation and feedback. |
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (2 listed)
- Primary care practice organizations with electronic health records.
- Located in Virginia
Key exclusion criteria (3 listed)
- Not a primary care practice.
- No electronic health record.
- Located outside of Virginia.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Mentored organizational changePractices are given basic education related to population-based care and are supported by physician peer mentors and given feedback on performance. | Other | Intervention |
| Education onlyPractices are given basic education related to population-based care and are given feedback on performance. | Other | Education only |
Primary outcome
Hemoglobin A1c
Time frame: Change in HbA1c from baseline to follow up (year 1 and year 2)
Assessment of HbA1c at baseline and two follow up points. Retrospective documentation of most recent value within previous year.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Oct 2017.
- Derived from this study: PubMed 32989067Sabo RT, Etz RS, Gonzalez MM, Johnson NJ, O'Neal JP, Reves SR, Crosson JC. Low-Intensity Intervention Supports Diabetes Registry Implementation: A Cluster-Randomized Trial in the Ambulatory Care Outcomes Research Network (ACORN). J Am Board Fam Med. 2020 Sep-Oct;33(5):728-735. doi: 10.3122/jabfm.2020.05.190455.
- Derived from this study: PubMed 28187747Keith RE, Crosson JC, O'Malley AS, Cromp D, Taylor EF. Using the Consolidated Framework for Implementation Research (CFIR) to produce actionable findings: a rapid-cycle evaluation approach to improving implementation. Implement Sci. 2017 Feb 10;12(1):15. doi: 10.1186/s13012-017-0550-7.
- Derived from this study: PubMed 25885661Etz RS, Keith RE, Maternick AM, Stein KL, Sabo RT, Hayes MS, Sevak P, Holland J, Crosson JC. Supporting Practices to Adopt Registry-Based Care (SPARC): protocol for a randomized controlled trial. Implement Sci. 2015 Apr 9;10:46. doi: 10.1186/s13012-015-0232-2.
Related trials for Diabetes Mellitus, Type 2
Recruiting
Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
Enrolling by invitation
MTM2MTG Pilot Ancillary Study
Diet, Healthy, HbA1c
Active, not recruiting
Metabolic and Inflammatory Outcomes of the Ketogenic Diet Comparing Saturated and Unsaturated Fat Sources
PreDiabetes, Diabetes Mellitus, Type 2
Not yet recruitingPhase 1/2
A Study Testing the Safety and Possible Benefits of an Ear Injection of a New Compound, Paliroden, in People With Type 2 Diabetes Who Have Difficulty Understanding Speech in Noisy Situations
Cochlear Synaptopathy
Not yet recruitingPhase 1
A Research Study to Check the Safety of NNC9836-0001 When Given to Healthy Participants and Participants With Type 2 Diabetes
Diabetes Mellitus, Type 2
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Jay Crosson, Ph.D. principal investigator
Mathematica Policy Research
Questions about this trial
What is this clinical trial studying?
A study testing Mentored organizational change and Education only in people with Diabetes Mellitus, Type 2, run by Mathematica Policy Research, Inc..
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 17 Oct 2017. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Hemoglobin A1c (time frame: Change in HbA1c from baseline to follow up (year 1 and year 2)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02318108, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Oct 2017.